SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-044667
Filing Date
2024-05-17
Accepted
2024-05-17 14:48:05
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206106-10q_bioess.htm   iXBRL 10-Q 497384
2 CERTIFICATION ea020610601ex31-1_bioess.htm EX-31.1 17193
3 CERTIFICATION ea020610601ex32-1_bioess.htm EX-32.1 10073
9 GRAPHIC image_001.jpg GRAPHIC 7168
  Complete submission text file 0001213900-24-044667.txt   4432722

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bioe-20240331.xsd EX-101.SCH 54483
5 XBRL CALCULATION FILE bioe-20240331_cal.xml EX-101.CAL 54773
6 XBRL DEFINITION FILE bioe-20240331_def.xml EX-101.DEF 236371
7 XBRL LABEL FILE bioe-20240331_lab.xml EX-101.LAB 413562
8 XBRL PRESENTATION FILE bioe-20240331_pre.xml EX-101.PRE 231458
79 EXTRACTED XBRL INSTANCE DOCUMENT ea0206106-10q_bioess_htm.xml XML 412723
Mailing Address 12 CHRYSLER UNIT B IRVINE CA 92618
Business Address 12 CHRYSLER UNIT B IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 24959090
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)